Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasmosis
Arch Soc Esp Oftalmol (Engl Ed). 2019 Dec;94(12):602-604.
doi: 10.1016/j.oftal.2019.09.005.
Epub 2019 Oct 10.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Oftalmología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España. Electronic address: lauratabuillueca@gmail.com.
- 2 Servicio de Oftalmología, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
- 3 Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
Abstract
Ocular toxoplasmosis is a disease than have severe consequences on the eyesight. The aim of this study article is to present a bilateral ocular toxoplasmosis in a sulfamide allergic patient with unilateral activation and her favourable progression with intravitreal Clindamycin and oral steroids treatment. Weekly intravitreal Clindamycin treatment is shown to be a suitable therapeutic alternative in cases of severe ocular toxoplasmosis and/or in patients with a contraindication to classical treatment. Intravitreal Clindamycin treatment is a safe alternative with favourable clinical results.
Keywords:
Chorioretinitis; Clindamicina intravítrea; Coriorretinitis; Intravitreal clindamycin; Toxoplasma gondii; Toxoplasmosis.
Copyright © 2019 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage*
-
Clindamycin / administration & dosage*
-
Female
-
Fluorescein Angiography
-
Humans
-
Intravitreal Injections
-
Tomography, Optical Coherence
-
Toxoplasmosis, Ocular / diagnostic imaging
-
Toxoplasmosis, Ocular / drug therapy*
Substances
-
Anti-Bacterial Agents
-
Clindamycin